Biotech Evelo Biosciences Announces New Clinical Candidate in Oncology and Presents Additional Interim Data from Phase 1/2 Clinical Trial of EDP1503 in Patients with Triple-Negative Breast Cancer December 9, 2020
Biotech Atossa Therapeutics Announces Pricing of $20.0 Million Underwritten Public Offering December 8, 2020
Biotech CTI BioPharma to Present at The JMP Securities Hematology Summit on Tuesday, Dec. 15 December 8, 2020
Biotech Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference December 7, 2020
Biotech Achieve Life Sciences, Inc. Announces Closing of $17.3 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option December 7, 2020